Skip to content

Clinical effect of Gu Mai Drink on gastrointestinal motility disorder with spleen and stomach weakness

Clinical effect of Gu Mai Drink on gastrointestinal motility disorder with spleen and stomach weakness

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000602
Enrollment
Unknown
Registered
2024-10-23
Start date
2023-04-01
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Motility Disorders

Interventions

treatment group:Gu Mai Drink
control group:domperidone tablets
acupuncture group:acupuncture

Sponsors

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Subjects who meet the diagnostic criteria of Western medicine as well as Chinese medicine symptoms of spleen and stomach deficiency and cold (weakness) type; 2) Age between 18~80 years old; 3) Have not taken any gastrointestinal prokinetic drugs at least 15 days before receiving treatment and have not participated in other clinical studies; 4) Those who sign the informed consent form inform the purpose process and duration of the clinical study and clearly inform the possible benefits and existing risks and voluntarily participate in the study.

Exclusion criteria

Exclusion criteria: 1) Patients with gastro-oesophageal reflux disease (GERD) irritable bowel syndrome functional diarrhoea abdominal pain constipation etc; 2) Patients with consciousness confusion inability to accurately express uncomfortable symptoms or a history of mental illness; 3) Patients with serious underlying diseases of cardiovascular and cerebrovascular and other systems or accompanied by malignant tumors; 4) Women who are pregnant or preparing to become pregnant lactating women; 5) People with allergies and allergies to multiple drugs.

Design outcomes

Primary

MeasureTime frame
Main symptom score scale;

Secondary

MeasureTime frame
TCM syndrome scale;PRO GRP;blood routine examination;The Nepean Dyspepsia Index (NDI);liver and kidney function tests;

Countries

China

Contacts

Public ContactZhao Haiyin

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Freshair1966@126.com18917763115

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026